SCHEMBL18166729

SCHEMBL18166729

CCOC(=O)c1nc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)sc1C

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 5/20 0.64
▸ TSHR P16473 2/20 0.64
▸ KDM4E B2RXH2 2/20 0.62
▸ ATM Q13315 1/20 0.62
▸ GAA P10253 1/20 0.61
▸ TP53 P04637 3/20 0.57
▸ CYP1A2 P05177 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ CYP2C9 P11712 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ THRB P10828 1/20 0.53
▸ ALOX15 P16050 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27814929 0.89 RXFP1 (0.60) RXFP1TSHRKDM4EATMTP53
SCHEMBL18166652 0.88 RXFP1 (0.65) RXFP1TSHRKDM4EATMGAA
SCHEMBL18166537 0.82 TSHR (0.78) RXFP1TSHRKDM4EATMGAA
SCHEMBL12584286 0.80 MAPT (0.61) RXFP1TSHRKDM4EATMTP53
SCHEMBL10114741 0.79 RXFP1 (0.83) RXFP1TSHRGAATP53CYP1A2
SCHEMBL18166597 0.78 RXFP1 (1.00) RXFP1TSHRKDM4EATMGAA
SCHEMBL10114157 0.78 POLB (0.60) RXFP1TSHRKDM4EATMTP53
SCHEMBL10114493 0.78 TSHR (1.00) RXFP1TSHRKDM4EGAATP53
SCHEMBL18166643 0.77 RXFP1 (0.72) RXFP1KDM4ETP53CYP1A2HSD17B10
SCHEMBL18166769 0.77 KDM4E (0.72) RXFP1TSHRKDM4EATMTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663295-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL ELI LILLY AND CO. (US) 2020-06-10 — — EP disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 — — EP disclosed
Send feedback